Stanley Kupchinsky - Concepedia

Author

Stanley Kupchinsky

Also Known As

Stanley Kupchinsky, Stanley W. Kupchinsky

Publications

165

Citations

H-Index

Concepts

All Affiliations

Stanley Kupchinsky is an author at Pfizer (United States) specializing in drug discovery, medicine, and pharmacology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	130
2	Natural Sciences	3	3	52
3	Biochemistry	3	3	131
4	Molecular Biology	2	2	41
5	Chemical Biology	1	1	20

Stanley Kupchinsky

Publications

163

Citations

H-Index

Page 1

	Year	Citations
Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer’s disease Christopher J. Helal, Mark A. Sanner, Christopher B. Cooper, Bioorganic & Medicinal Chemistry Letters Drug TargetAlzheimer's DiseaseBiochemistryCyclin-dependent Kinase 5/P25Medicine	2004	99
Design, synthesis, and biological evaluation of novel human 5′-deoxy-5′-methylthioadenosine phosphorylase (MTAP) substrates Pei-Pei Kung, Luke R. Zehnder, Jerry Meng, Bioorganic & Medicinal Chemistry Letters BiosynthesisBiochemistryNatural SciencesMolecular BiologyBiological Evaluation	2005	21
A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties Stanley Kupchinsky, Sara Centioni, Tiffany T. Howard, Bioorganic & Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryPharmaceutical ScienceBioorganic ChemistryDna Binding	2004	20
Novel platinum(II) derivatives of analogues of netropsin and distamycin: Synthesis, DNA binding and cytotoxic properties Moses Lee, Jacob E. Simpson, Adrienne J. Burns, UCL Discovery (University College London)	1996	12
N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11β-hydroxysteroid dehydrogenase type 1: Strategies to eliminate reactive metabolites Sajiv K. Nair, Jean Matthews, Stephan J. Cripps, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryReactive MetabolitesBiochemistryMedicineNatural Sciences	2013	11

Page 1